Search

everythinglearnresearchcommunity

for

Search:↓

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

iPSCs are promising for studying and treating COVID-19.

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.

Nanoparticles may improve treatment for lung disease by targeting cells better and reducing side effects.

Brentuximab may cause hair to regain color.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

An 8-year-old girl developed a rare skin condition in a linear pattern on one side of her body after a lung infection, which improved with treatment.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

Stopping isoniazid can reverse hair loss caused by the drug.

mTOR inhibitors may help treat lung fibrosis.

Blocking specific proteins can help remove aging cells and might treat age-related diseases and promote hair growth.

Metformin, a diabetes drug, may help prevent and treat various cancers, but more research is needed.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Monocyclic aromatic compounds are important for developing various drugs and treatments.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Isoniazid can rarely cause hair loss, which is reversible after stopping the drug.

Some medications can cause acne, and stopping these drugs is the main treatment.

64 drugs can cause hair loss, needing better monitoring and updated labels.

More research is needed to understand chemotherapy-induced hair loss and its phases.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

Hypoxia and epigenetics are crucial for cell growth and tissue regeneration.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.